Consider TIPS in Treating Portal Hypertension
Time to Rethink TIPS
Advanced by compelling evidence, earlier transjugular intrahepatic portosystemic shunt (TIPS) is helping physicians increase survival in high-risk liver disease patients.
Higher transplant-free survival for recurrent ascites at one year*,1
Higher survival in Child-Pugh C patients with acute variceal bleeding (AVB) at one year†,2
93% TIPS
vs. 52% large-volume paracenteses (LVP) +albumin (A) (P =.003)
78% TIPS
vs. 53% pharmacotherapy + endoscopic band ligation (EBL) (P =.002)
* Early TIPS (n = 29) compared to large-volume paracenteses and albumin infusion (LVP+A) (n = 33).
† Early TIPS (n = 66) compared to pharmacotherapy+endoscopic band ligation (EBL) (n = 605). Child-Pugh C patients with scores < 14.
- Bureau C, Thabut D, Oberti D, et al. Transjugular intrahepatic portosystemic shunts with covered stents increase transplant-free survival of patients with cirrhosis and recurrent ascites. Gastroenterology 2017;152(1):157-163. http://www.sciencedirect.com/science/article/pii/S0016508516351101
- Hernández-Gea V, Procopet B, Giráldez Á, et al; International Variceal Bleeding Observational Study Group and Baveno Cooperation. Preemptive-TIPS improves outcome in high-risk variceal bleeding: an observational study. Hepatology 2019;69(1):282-293. https://aasldpubs.onlinelibrary.wiley.com/doi/full/10.1002/hep.30182
Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. RXOnly
INDICATIONS FOR USE IN EUROPE: The GORE® VIATORR® TIPS Endoprosthesis with Controlled Expansion is indicated for use in the treatment of portal hypertension and its complications such as variceal bleeding and refractory ascites.
CONTRAINDICATIONS: There are no known contraindications for this device.